Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1714027

registered interest
date	26/04/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sipavibart
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the oral contribution by the Parliamentary Under Secretary of State at the Department of Health and Social Care during the debate on Covid-19: Response and Excess Deaths on Thursday 18 April 2024, Official Report, column 537, whether she has had recent discussions with (a) NICE and (b) the MHRA on their progress on reaching a decision on whether to recommend the use of Evusheld 2 to prevent covid-19.
tabling member constituency	Christchurch
tabling member printed	Sir Christopher Chope
uin	23829
answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The Department meets with the National Institute of Health and Care Excellence (NICE) regularly to discuss a range of issues, including access to medicines. The NICE has formally started its appraisal of AZD-3152, also known as sipavibart and referred to as Evusheld 2, ahead of the Medicines and Healthcare products Regulatory Agency’s (MHRA) decision on whether it should be given a United Kingdom marketing authorisation, and expects to invite stakeholder submissions in April 2024. Timelines for both the NICE’s guidance and licensing depend on data from the SUPERNOVA trial being available. AstraZeneca intends to submit clinical data to the NICE and the MHRA at the same time, with the aim that both organisations are able to reach decisions as close together as possible. If AZD-3152 is recommended as clinically and cost effective by the NICE, the National Health Service in England will be under a statutory requirement to fund AZD-3152 for eligible patients, in line with the NICE’s recommendations.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 01/05/2024 08:57:40 answering member 4044 label Biography information for Andrew Stephenson
tabling member	242 label Biography information for Sir Christopher Chope

1472804

registered interest
date	23/06/2022
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Environment Protection: Public Appointments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, if he will publish the terms of reference for the 25 Year Environment Plan Board.
tabling member constituency	Luton South
tabling member printed	Rachel Hopkins
uin	23829
answer	answer is ministerial correction date of answer 01/07/2022 answer text <p>The Defra-led cross-Government 25 Year Environment Plan Board was established in December 2020. The Board is responsible for overseeing, co-ordinating and driving forward action to implement the 25 Year Environment Plan and associated requirements under the Environment Act 2021. It aims to join up, secure and accelerate action across government to deliver the Government's commitment of leaving the environment in a better state than we found it. It focuses on delivering the ten goals set out in the Plan, as well as implementation of the Government's 30x30 commitment and the Greening Government Commitments.</p> answering member constituency Taunton Deane answering member printed Rebecca Pow grouped question UIN 23830 question first answered 01/07/2022 13:05:12 answering member 4522 label Biography information for Rebecca Pow
tabling member	4873 label Biography information for Rachel Hopkins

447282

registered interest
date	25/01/2016
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Young Offender Institutions: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Justice, what proportion of staff employed in each young offender institution is registered with the Mental Health and Care Professions Council.
tabling member constituency	Hammersmith
tabling member printed	Andy Slaughter
uin	23829
answer	answer is ministerial correction date of answer 02/02/2016 answer text <p>The information requested could only be provided at disproportionate costs.</p><p>The Youth Justice Board is responsible for commissioning and oversight of the secure youth estate. The Youth Justice Board funds dedicated social workers at each under-18 Young Offender Institution (YOI). All young people undergo a health and education assessment upon arrival into custody, whilst all staff undergo training in child and adolescent development and safeguarding.</p><p>Under-18 YOI providers should ensure that they meet the needs of all detained persons including those with Special Education and Needs (SEN) requirements, and that all staff are suitably qualified to support young people and make referrals to other specialist support where this is appropriate.</p> answering member constituency South West Bedfordshire answering member printed Andrew Selous grouped question UIN 23824 23826 23849 question first answered 02/02/2016 15:45:14 answering member 1453 label Biography information for Andrew Selous
tabling member	1516 label Biography information for Andy Slaughter